These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 8162565

  • 21. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
    Horowitz J.
    Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
    [Abstract] [Full Text] [Related]

  • 22. Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transfer.
    Miyake H, Hanada N, Nakamura H, Kagawa S, Fujiwara T, Hara I, Eto H, Gohji K, Arakawa S, Kamidono S, Saya H.
    Oncogene; 1998 Feb 19; 16(7):933-43. PubMed ID: 9484785
    [Abstract] [Full Text] [Related]

  • 23. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis.
    Fujiwara T, Grimm EA, Mukhopadhyay T, Cai DW, Owen-Schaub LB, Roth JA.
    Cancer Res; 1993 Sep 15; 53(18):4129-33. PubMed ID: 8395976
    [Abstract] [Full Text] [Related]

  • 24. ONYX-015 works synergistically with chemotherapy in lung cancer cell lines and primary cultures freshly made from lung cancer patients.
    You L, Yang CT, Jablons DM.
    Cancer Res; 2000 Feb 15; 60(4):1009-13. PubMed ID: 10706117
    [Abstract] [Full Text] [Related]

  • 25. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
    Määttä AM, Tenhunen A, Pasanen T, Meriläinen O, Pellinen R, Mäkinen K, Alhava E, Wahlfors J.
    Int J Oncol; 2004 Apr 15; 24(4):943-9. PubMed ID: 15010834
    [Abstract] [Full Text] [Related]

  • 26. [Experimental study on adenovirus-mediated transfer of p53 or adenovirus- mediated transfer of p53 combined with radiotherapy for human cervical cancer cell line HeLa cells].
    Kong W, Sun J, Lin C, Zha Y, Lu G, Fu M, Zhang X.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Jun 18; 37(6):352-5. PubMed ID: 12126571
    [Abstract] [Full Text] [Related]

  • 27. Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cell line heterotransplants in nude mice.
    Zhang YA, Nemunaitis J, Scanlon KJ, Tong AW.
    Gene Ther; 2000 Dec 18; 7(23):2041-50. PubMed ID: 11175317
    [Abstract] [Full Text] [Related]

  • 28. Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer.
    Kandioler D, Stamatis G, Eberhardt W, Kappel S, Zöchbauer-Müller S, Kührer I, Mittlböck M, Zwrtek R, Aigner C, Bichler C, Tichy V, Hudec M, Bachleitner T, End A, Müller MR, Roth E, Klepetko W.
    J Thorac Cardiovasc Surg; 2008 May 18; 135(5):1036-41. PubMed ID: 18455581
    [Abstract] [Full Text] [Related]

  • 29. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ, Kong MJ, Ma ZY, Qian JF, Fan JQ, Xu XH.
    Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1506-9. PubMed ID: 17785094
    [Abstract] [Full Text] [Related]

  • 30. Cancer gene therapy using a novel adeno-associated virus vector expressing human wild-type p53.
    Qazilbash MH, Xiao X, Seth P, Cowan KH, Walsh CE.
    Gene Ther; 1997 Jul 05; 4(7):675-82. PubMed ID: 9282168
    [Abstract] [Full Text] [Related]

  • 31. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells.
    Choi SH, Jin SE, Lee MK, Lim SJ, Park JS, Kim BG, Ahn WS, Kim CK.
    Eur J Pharm Biopharm; 2008 Mar 05; 68(3):545-54. PubMed ID: 17881199
    [Abstract] [Full Text] [Related]

  • 32. Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells.
    Kigawa J, Sato S, Shimada M, Kanamori Y, Itamochi H, Terakawa N.
    Gynecol Oncol; 2002 Feb 05; 84(2):210-5. PubMed ID: 11812076
    [Abstract] [Full Text] [Related]

  • 33. [Gene therapy with tumor suppressor gene p53 and(or) p16 on the nude mice models of NSCLC in vivo].
    Wu W, Zhang X, Qi X.
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jul 05; 23(7):403-5. PubMed ID: 11778504
    [Abstract] [Full Text] [Related]

  • 34. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK, Meeran SM, Katiyar N, Akhtar S.
    Mol Carcinog; 2009 Jan 05; 48(1):24-37. PubMed ID: 18459128
    [Abstract] [Full Text] [Related]

  • 35. Reduced telomeric signals and increased telomeric associations in human lung cancer cell lines undergoing p53-mediated apoptosis.
    Mukhopadhyay T, Multani AS, Roth JA, Pathak S.
    Oncogene; 1998 Aug 20; 17(7):901-6. PubMed ID: 9780006
    [Abstract] [Full Text] [Related]

  • 36. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC, Zunino F.
    Cancer Res; 1996 Feb 01; 56(3):556-62. PubMed ID: 8564971
    [Abstract] [Full Text] [Related]

  • 37. Induction of p53-mediated apoptosis and recovery of chemosensitivity through p53 transduction in human glioblastoma cells by cisplatin.
    Park CM, Park MJ, Kwak HJ, Moon SI, Yoo DH, Lee HC, Park IC, Rhee CH, Hong SI.
    Int J Oncol; 2006 Jan 01; 28(1):119-25. PubMed ID: 16327987
    [Abstract] [Full Text] [Related]

  • 38. Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells.
    Chang FL, Ling YF, Lai MD.
    Anticancer Res; 2000 Jan 01; 20(1A):329-36. PubMed ID: 10769676
    [Abstract] [Full Text] [Related]

  • 39. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M, Sasaki Y, Suzuki H, Mita H, Imai K, Shinomura Y, Tokino T.
    Clin Cancer Res; 2009 Jun 01; 15(11):3725-32. PubMed ID: 19458054
    [Abstract] [Full Text] [Related]

  • 40. [The combination of recombinant rAd-p53 and adriamycin for management of primary drug resistance in chemotherapy of lung squamous cell cancer].
    Du CH, Wu Z, Xu J.
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep 01; 29(9):622-4. PubMed ID: 17129471
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.